Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CYGNUS-C Standalone ACIF System

K-Number: K222041 · 2023-02-09

Decision Date2023-02-09
Product CodeOVE
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

CYGNUS-C Standalone ACIF System is a medical device manufactured by GS Medical Co., Ltd.. It received FDA 510(k) clearance on 2023-02-09 under approval number K222041. The device is classified under product code OVE. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CYGNUS-C Standalone ACIF System?

CYGNUS-C Standalone ACIF System is a medical device that received FDA 510(k) clearance on 2023-02-09. It is manufactured by GS Medical Co., Ltd.. The 510(k) number is K222041.

When was CYGNUS-C Standalone ACIF System approved by the FDA?

CYGNUS-C Standalone ACIF System received FDA 510(k) clearance on 2023-02-09, under approval number K222041.

What company makes CYGNUS-C Standalone ACIF System?

CYGNUS-C Standalone ACIF System is manufactured by GS Medical Co., Ltd..

What is the FDA product code for CYGNUS-C Standalone ACIF System?

The FDA product code for CYGNUS-C Standalone ACIF System is OVE.

Related Clinical Trials

Other Devices by GS Medical Co., Ltd.

View all 13 devices →

Related Devices (Code: OVE)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.